Iqvia Holdings Inc.
A health-intelligence giant that helps drugmakers run clinical trials, sell their medicines, and make sense of huge piles of healthcare data—drawing on a trove covering roughly nine in ten of the world's pharmaceuticals. It was born in 2016 when Quintiles, the contract-research firm founded by a statistics professor in 1982, merged with IMS Health, a market-data company from 1954. Its name blends letters from both: the "I" from IMS and "Q" from Quintiles, plus "VIA" for the road ahead.
Granted 184.8K · Sold 93.1K
Granted 16.3K
Granted 1.6K
Granted 11.8K
Granted 16.8K · Sold 4.0K
Granted 8.3K
Granted 2.7K
Granted 1.6K
Granted 1.6K
Granted 6.7K
Granted 2.7K
Granted 1.6K
Granted 4.1K
Granted 1.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bousbib AriSee Remarks, Director · 13 transactions | +2% | 1.41M | 184.8K | — | 93.1K |
| Bruehlman Ronald ESee Remarks · 2 transactions | +20.5% | 56.0K | 16.3K | — | — |
| Danhakl John GDirector · 1 transaction | +5.2% | 31.9K | 1.6K | — | — |
| Grenfell AlistairSee Remarks · 2 transactions | — | 29.7K | 11.8K | — | — |
| Sherbet EricSee Remarks · 5 transactions | +32.2% | 27.9K | 16.8K | — | 4.0K |
| Haas BerndSee Remarks · 3 transactions | — | 24.4K | 8.3K | — | — |
| Staub W RichardSee Remarks · 2 transactions | +16.1% | 19.6K | 2.7K | — | — |
| Leonard John MDirector · 1 transaction | +10.2% | 16.9K | 1.6K | — | — |
| Goggins Colleen ADirector · 1 transaction | +12.2% | 14.5K | 1.6K | — | — |
| Fedock Michael J.See Remarks · 5 transactions | — | 9.5K | 6.7K | — | — |
| Berkshire James G.See Remarks · 2 transactions | — | 8.2K | 2.7K | — | — |
| Burt CarolDirector · 1 transaction | +26.4% | 7.5K | 1.6K | — | — |
| Patel BhavikSee Remarks · 2 transactions | +392.6% | 5.1K | 4.1K | — | — |
| Cherofsky KeriannSee Remarks · 2 transactions | +23.4% | 3.5K | 1.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -97.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.